ID E2F2_MOUSE Reviewed; 443 AA. AC P56931; A2AW43; Q8BID0; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 30-AUG-2005, sequence version 2. DT 27-MAR-2024, entry version 175. DE RecName: Full=Transcription factor E2F2; DE Short=E2F-2; GN Name=E2f2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Eye; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PRELIMINARY NUCLEOTIDE SEQUENCE OF 49-254, AND DEVELOPMENTAL STAGE. RC TISSUE=Embryo; RX PubMed=9149906; RA Dagnino L., Fry C.J., Bartley S.M., Farnham P., Gallie B.L., Phillips R.A.; RT "Expression patterns of the E2F family of transcription factors during RT murine epithelial development."; RL Cell Growth Differ. 8:553-563(1997). RN [5] RP DEVELOPMENTAL STAGE. RX PubMed=9376316; DOI=10.1016/s0925-4773(97)00083-x; RA Dagnino L., Fry C.J., Bartley S.M., Farnham P., Gallie B.L., Phillips R.A.; RT "Expression patterns of the E2F family of transcription factors during RT mouse nervous system development."; RL Mech. Dev. 66:13-25(1997). RN [6] RP INTERACTION WITH EAPP. RX PubMed=15716352; DOI=10.1091/mbc.e04-11-0975; RA Novy M., Pohn R., Andorfer P., Novy-Weiland T., Galos B., Schwarzmayr L., RA Rotheneder H.; RT "EAPP, a novel E2F binding protein that modulates E2F-dependent RT transcription."; RL Mol. Biol. Cell 16:2181-2190(2005). CC -!- FUNCTION: Transcription activator that binds DNA cooperatively with DP CC proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in CC the promoter region of a number of genes whose products are involved in CC cell cycle regulation or in DNA replication. The DRTF1/E2F complex CC functions in the control of cell-cycle progression from g1 to s phase. CC E2F2 binds specifically to RB1 in a cell-cycle dependent manner. CC -!- SUBUNIT: Component of the DRTF1/E2F transcription factor complex. Forms CC heterodimers with DP family members. The E2F2 complex binds CC specifically hypophosphorylated retinoblastoma protein RB1. During the CC cell cycle, RB1 becomes phosphorylated in mid-to-late G1 phase, CC detaches from the DRTF1/E2F complex, rendering E2F transcriptionally CC active. Viral oncoproteins, notably E1A, T-antigen and HPV E7, are CC capable of sequestering RB protein, thus releasing the active complex. CC Binds EAPP. CC -!- SUBCELLULAR LOCATION: Nucleus. CC -!- DEVELOPMENTAL STAGE: Expressed in the developing epidermis and CC intestinal epithelium. First detected in the epidermis at stage 13.5- CC 14.5 dpc with higher levels in the head and thorax regions. At 15.5 CC dpc, expression is found in both the epithelium and, to a lesser extent CC in the underlying mesenchyme. At day 16.5 dpc, high expression in the CC basal cells. Later expression is found in the developing hair CC follicles, around the dermal papillae. In the developing intestinal CC epithelium, expression first observed around 14.5 dpc. Levels continue CC to increase at least until 19.5 dpc, with highest levels in the CC intervillus epithelium and in the bottom half of the villi. In the CC nervous system, first expressed at 9.5 dpc, in the forebrain. At 10.5 CC dpc, expressed broadly in the brain, and at lower levels in the upper CC regions of the spinal cord. By 11.5 dpc, E2F2 expression is found CC throughout the central nervous system and levels peak at 12.5-15.5 dpc. CC In the developing spinal cord, E2F2 expression found only in the dorsal CC region. In the developing retina, highest expression found in the 14.5- CC 18.5 dpc embryonic retinoblastic cell layer. In other developing CC tissues, E2F2 is found highest in thymus and liver, with lower CC expression in lung, heart, kidney and skeletal muscle. Also found in CC choroid plexus and chondrocytes. {ECO:0000269|PubMed:9149906, CC ECO:0000269|PubMed:9376316}. CC -!- PTM: Phosphorylated by CDK2 and cyclin A-CDK2 in the S-phase. CC {ECO:0000250}. CC -!- SIMILARITY: Belongs to the E2F/DP family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK087452; BAC39881.1; -; mRNA. DR EMBL; AL935264; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC062101; AAH62101.1; -; mRNA. DR CCDS; CCDS18801.1; -. DR RefSeq; NP_001292328.1; NM_001305399.1. DR RefSeq; NP_808401.1; NM_177733.7. DR AlphaFoldDB; P56931; -. DR SMR; P56931; -. DR BioGRID; 232447; 3. DR ComplexPortal; CPX-176; E2F2-DP1 transcription factor complex. DR ComplexPortal; CPX-177; RB1-E2F2-DP1 transcription repressor complex. DR CORUM; P56931; -. DR DIP; DIP-48416N; -. DR IntAct; P56931; 3. DR STRING; 10090.ENSMUSP00000050047; -. DR iPTMnet; P56931; -. DR PhosphoSitePlus; P56931; -. DR EPD; P56931; -. DR jPOST; P56931; -. DR PaxDb; 10090-ENSMUSP00000050047; -. DR ProteomicsDB; 277699; -. DR Antibodypedia; 4274; 392 antibodies from 36 providers. DR DNASU; 242705; -. DR Ensembl; ENSMUST00000061721.6; ENSMUSP00000050047.6; ENSMUSG00000018983.10. DR GeneID; 242705; -. DR KEGG; mmu:242705; -. DR UCSC; uc008vht.3; mouse. DR AGR; MGI:1096341; -. DR CTD; 1870; -. DR MGI; MGI:1096341; E2f2. DR VEuPathDB; HostDB:ENSMUSG00000018983; -. DR eggNOG; KOG2577; Eukaryota. DR GeneTree; ENSGT00940000160992; -. DR HOGENOM; CLU_032091_0_0_1; -. DR InParanoid; P56931; -. DR OMA; WVGRGIF; -. DR OrthoDB; 1761at2759; -. DR PhylomeDB; P56931; -. DR TreeFam; TF105566; -. DR Reactome; R-MMU-69231; Cyclin D associated events in G1. DR BioGRID-ORCS; 242705; 7 hits in 62 CRISPR screens. DR ChiTaRS; E2f2; mouse. DR PRO; PR:P56931; -. DR Proteomes; UP000000589; Chromosome 4. DR RNAct; P56931; Protein. DR Bgee; ENSMUSG00000018983; Expressed in blood and 168 other cell types or tissues. DR GO; GO:0005634; C:nucleus; IDA:MGI. DR GO; GO:0035189; C:Rb-E2F complex; ISS:ComplexPortal. DR GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:MGI. DR GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:MGI. DR GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:MGI. DR GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:MGI. DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central. DR GO; GO:0046983; F:protein dimerization activity; IEA:InterPro. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central. DR GO; GO:0043565; F:sequence-specific DNA binding; ISO:MGI. DR GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:MGI. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IDA:MGI. DR GO; GO:1990086; P:lens fiber cell apoptotic process; IDA:MGI. DR GO; GO:1903671; P:negative regulation of sprouting angiogenesis; ISO:MGI. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI. DR GO; GO:0051726; P:regulation of cell cycle; IDA:MGI. DR GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:MGI. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central. DR CDD; cd14660; E2F_DD; 1. DR Gene3D; 6.10.250.540; -; 1. DR Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1. DR InterPro; IPR015633; E2F. DR InterPro; IPR037241; E2F-DP_heterodim. DR InterPro; IPR032198; E2F_CC-MB. DR InterPro; IPR003316; E2F_WHTH_DNA-bd_dom. DR InterPro; IPR036388; WH-like_DNA-bd_sf. DR InterPro; IPR036390; WH_DNA-bd_sf. DR PANTHER; PTHR12081; TRANSCRIPTION FACTOR E2F; 1. DR PANTHER; PTHR12081:SF50; TRANSCRIPTION FACTOR E2F2; 1. DR Pfam; PF16421; E2F_CC-MB; 1. DR Pfam; PF02319; E2F_TDP; 1. DR SMART; SM01372; E2F_TDP; 1. DR SUPFAM; SSF144074; E2F-DP heterodimerization region; 1. DR SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1. DR Genevisible; P56931; MM. PE 1: Evidence at protein level; KW Activator; Cell cycle; DNA-binding; Nucleus; Phosphoprotein; KW Reference proteome; Transcription; Transcription regulation. FT CHAIN 1..443 FT /note="Transcription factor E2F2" FT /id="PRO_0000219465" FT DNA_BIND 109..198 FT /evidence="ECO:0000255" FT REGION 1..22 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 67..107 FT /note="Cyclin A/CDK2 binding" FT /evidence="ECO:0000255" FT REGION 157..178 FT /note="Leucine-zipper" FT REGION 199..291 FT /note="Dimerization" FT /evidence="ECO:0000255" FT REGION 306..341 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 361..443 FT /note="Transactivation" FT /evidence="ECO:0000255" FT REGION 416..433 FT /note="Retinoblastoma protein binding" FT /evidence="ECO:0000255" FT MOTIF 162..198 FT /note="DEF box" SQ SEQUENCE 443 AA; 48499 MW; DFC8158E5A8254F0 CRC64; MLRAPRTLAP ATAQPTKSLP ALNPTELWPS GLSSPQLCPA TTATTYYTSL YTQTVPSSVA LGTCLDATPH GPEGQIVRCA PAGRLPAKRK LDLEGIGRPT VPEFRTPKGK CIRVDGLPSP KTPKSPGEKT RYDTSLGLLT KKFIYLLSES EDGVLDLNWA AEVLDVQKRR IYDITNVLEG IQLIRKKSKN NIQWVGRELF EDPTRPSRQQ QLGQELKELM NAEQTLDQLI QSCSLSFKHL TEDNANKKLA YVTYQDIRAV GNFKEQTVIA VKAPPQTRLE VPDRAEENLQ IYLKSTQGPI EVYLCPEEGQ EPDSPAKEAL PSTSALSPIP DCAQPGCSTD SGIAETIEPS VLIPQPIPPP PPPPLPPAPS LVPLEATDNM LELSHPLLQQ TEDQFLSPIL AANSPLISFS PPLDQDEYLW GMDEGEGISD LFDSYDLGDL LIN //